ReviewCanadian family physician Medecin de famille canadien2013
New approach to managing genital warts.
Review in Canadian family physician Medecin de famille canadien, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 33 citations in OpenAlex.
- Review
- Success of Intralesional Purified Protein Derivative Immunotherapy in the Treatment of Anogenital Warts: A Case Report.Journal of experimental pharmacology · 2022Article
- Correlation of the ALA-PDT Treatment Efficacy and the HPV Genotype Profile of Genital Warts after Cryotherapy Failure and Podophyllotoxin Therapy in Male Patients.Life (Basel, Switzerland) · 2021Article
- Carbon dioxide (COCase reports in women's health · 2020Article
- HPV infection in urology practice.International urology and nephrology · 2020Review
- Cryotherapy of Genital Warts.Materia socio-medica · 2019Article
- Position statement for the diagnosis and management of anogenital warts.Journal of the European Academy of Dermatology and Venereology : JEADV · 2019Article
- Genital warts treatment: Beyond imiquimod.Human vaccines & immunotherapeutics · 2018Review
- [Anogenital warts and HPV-associated precancers : Looking into the recently passed German S2k guideline].Der Urologe. Ausg. A · 2018Review
- Penile warts: an update on their evaluation and management.Drugs in context · 2018Review
- Recurrent and Sustained Viral Infections in Primary Immunodeficiencies.Frontiers in immunology · 2017Review
- Approved Antiviral Drugs over the Past 50 Years.Clinical microbiology reviews · 2016Review
- Treatment of condyloma acuminata in pregnant women with cryotherapy combined with proanthocyanidins: Outcome and safety.Experimental and therapeutic medicine · 2016Article
- Quality of life in men diagnosed with anogenital warts.Anais brasileiros de dermatologiaArticle
- Successful management of recalcitrant perianal warts with two sessions of intralesional 5-fluorouracil.Indian journal of sexually transmitted diseases and AIDSArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo summarize and determine the appropriate use for the new and old management tools for genital warts. SOURCES OF INFORMATION: The following databases were searched: MEDLINE, PubMed, EMBASE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, ACP Journal Club, and Trip. The bibliographies of retrieved papers were also reviewed. Clinical trials, qualitative review articles, consensus reports, and clinical practice guidelines were retrieved. MAIN MESSAGE: Symptomatic warts are prevalent in at least 1% of the population between the ages of 15 and 49, with estimates of up to 50% of the population being infected with human papillomavirus at some point in their lifetime. Imiquimod and podophyllotoxin are 2 new treatments for external genital warts that are less painful and can be applied by patients at home. In addition, the quadrivalent human papillomavirus vaccine has been shown to be efficacious in preventing genital warts and cervical cancer. There is still a role for the older treatment methods in certain situations, such as intravaginal, urethral, anal, or recalcitrant warts; or for pregnant patients.
conclusionThe new treatments of external genital warts can reduce the pain of treatment and the number of office visits. Other treatment methods are still useful in certain situations.
Indexed as
Identifiers
23851535PMC3710035W2134424414What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.